Scott C Baraban1. 1. Epilepsy Research Laboratory, Department of Neurological Surgery, University of California, San Francisco, CA 94143, USA. Scott.Baraban@ucsf.edu
Abstract
PURPOSE OF REVIEW: Animal models provide a means to investigate fundamental mechanisms of abnormal electrical discharge (i.e., seizures). Understanding the pathogenesis of epilepsy and therapy development have greatly benefited from these models. Here we review recent mouse mutants featuring spontaneous seizures and simpler organisms. RECENT FINDINGS: New genetically engineered mice provide additional insights to cellular mechanisms underlying seizure generation (BK calcium-activated potassium channels and interneuron-expressed sodium channels), genetic interactions that exacerbate seizure phenotype (Scn2a, Kcnq2 and background) and neurodevelopmental influences (Dlx transcription factors). Mutants for neuronal nicotinic acetylcholine receptors, Glut-1 deficiency and aquaporin channels highlight additional seizure phenotypes in mice. Additional models in Caenorhabditis elegans (Lis-1) and Danio rerio (pentylenetetrazole) highlight a reductionist approach. Taking further advantage of 'simple' organisms, antiepileptic drugs and genetic modifiers of seizure activity are being uncovered in Drosophila. SUMMARY: Studies of epilepsy in mutant mice provide a framework for understanding critical features of the brain that regulate excitability. These, and as yet undiscovered, mouse mutants will continue to serve as the foundation for basic epilepsy research. Interestingly, an even greater potential for analyzing epileptic phenotypes may lie in the more widespread use of genetically tractable organisms such as worms, flies and zebrafish.
PURPOSE OF REVIEW: Animal models provide a means to investigate fundamental mechanisms of abnormal electrical discharge (i.e., seizures). Understanding the pathogenesis of epilepsy and therapy development have greatly benefited from these models. Here we review recent mouse mutants featuring spontaneous seizures and simpler organisms. RECENT FINDINGS: New genetically engineered mice provide additional insights to cellular mechanisms underlying seizure generation (BK calcium-activated potassium channels and interneuron-expressed sodium channels), genetic interactions that exacerbate seizure phenotype (Scn2a, Kcnq2 and background) and neurodevelopmental influences (Dlx transcription factors). Mutants for neuronal nicotinic acetylcholine receptors, Glut-1 deficiency and aquaporin channels highlight additional seizure phenotypes in mice. Additional models in Caenorhabditis elegans (Lis-1) and Danio rerio (pentylenetetrazole) highlight a reductionist approach. Taking further advantage of 'simple' organisms, antiepileptic drugs and genetic modifiers of seizure activity are being uncovered in Drosophila. SUMMARY: Studies of epilepsy in mutant mice provide a framework for understanding critical features of the brain that regulate excitability. These, and as yet undiscovered, mouse mutants will continue to serve as the foundation for basic epilepsy research. Interestingly, an even greater potential for analyzing epileptic phenotypes may lie in the more widespread use of genetically tractable organisms such as worms, flies and zebrafish.
Authors: B P Keogh; D Cordes; L Stanberry; B D Figler; C A Robbins; B L Tempel; C G Green; A Emmi; K M Maravilla; P A Schwartzkroin Journal: Epilepsy Res Date: 2005 Aug-Sep Impact factor: 3.045
Authors: Frank H Yu; Massimo Mantegazza; Ruth E Westenbroek; Carol A Robbins; Franck Kalume; Kimberly A Burton; William J Spain; G Stanley McKnight; Todd Scheuer; William A Catterall Journal: Nat Neurosci Date: 2006-08-20 Impact factor: 24.884
Authors: Robby M Weimer; Janet E Richmond; Warren S Davis; Gayla Hadwiger; Michael L Nonet; Erik M Jorgensen Journal: Nat Neurosci Date: 2003-09-14 Impact factor: 24.884
Authors: Devin K Binder; Xiaoming Yao; Zsolt Zador; Thomas J Sick; Alan S Verkman; Geoffrey T Manley Journal: Glia Date: 2006-04-15 Impact factor: 7.452
Authors: Yang Liu; Savannah Dale; Rebecca Ball; Ariel J VanLeuven; Andrew Sornborger; James D Lauderdale; Peter Kner Journal: Neurophotonics Date: 2019-03-05 Impact factor: 3.593
Authors: Xiaoyang Li; Richard A Himes; Lyndsey C Prosser; Charleston F Christie; Emma Watt; Sharon F Edwards; Cameron S Metcalf; Peter J West; Karen S Wilcox; Sherine S L Chan; C James Chou Journal: J Med Chem Date: 2020-05-22 Impact factor: 7.446
Authors: Olivia Erin Buenafe; Adriana Orellana-Paucar; Jan Maes; Hao Huang; Xuhui Ying; Wim De Borggraeve; Alexander D Crawford; Walter Luyten; Camila V Esguerra; Peter de Witte Journal: ACS Chem Neurosci Date: 2013-09-06 Impact factor: 4.418
Authors: Indrani Rajan; Katerina V Savelieva; Gui-Lan Ye; Ching-Yun Wang; Murtaza M Malbari; Carl Friddle; Thomas H Lanthorn; Wandong Zhang Journal: PLoS One Date: 2009-08-12 Impact factor: 3.240